(385) Hypothalamic Estrogen Receptor Antagonists May Have A Prognostic Role In Subclinical Hypogonadism In Patients With Erectile Dysfunction And Infertility
Dr Iurii Arian,Prof Ion Dumbraveanu,Dr Victoria Ghenciu,Dr Mariana Creciun,Prof Emil Ceban
DOI: https://doi.org/10.1093/jsxmed/qdae041.057
2024-06-15
The Journal of Sexual Medicine
Abstract:Objectives It is already a common clinical practice to not use hypothalamic estrogen receptor antagonists and aromatase inhibitors in hypergonadotropic hypogonadism, as gonadotropins will rise. From clinical observation, normo-gonadotropic hypogonadal males may have elevated gonadotropin levels on hypothalamic estrogen receptor antagonists. The purpose of this study is to evaluate erectile function, hormonal and semen parameters changes in clomiphene-induced high LH and FSH levels. Methods A retrospective study was done on 83 normo-gonadotropic hypogonadal males with symptoms of ED and infertility, mean age 35,56±9,09 years, to whom treatment with Clomiphene citrate was recommended, and at follow-up visits, elevated gonadotropins were found. Pre-treatment and on treatment LH (mIU/mL), FSH (mIU/mL), total T (ng/dL), E (pg/mL), and semen parameters were compared. IIEF-5 scoring was used for ED evaluation. Results Accordingly, with IIEF-5 scoring, 17.5% reported severe ED, 31.3% with moderate, 21% with mild-moderate, and 31.2% with mild ED. Before treatment hormones and semen mean values: LH (4.04±3.62), FSH (5.43±4.62), total T (208±87.9), E (27.4±15.22), sperm concentration (12.45±8.61), PR motility (27.56±18.13). On treatment 28 (33.73%) male were found with LH only high level with mean value 13.54±6.48. 55 (66.27%) male with Clomiphene induced hypergonadotropic (LH and FSH) hypogonadism was reported with semen and hormonal mean values: LH (12.04±4.98), FSH (15.43±5.62), total T (475.8±244.9), E (48.4±19.22), sperm concentration (18.15±12.87), PR motility (36.56±13.47). In 13 (15.66%) induced high LH and FSH males, semen parameters got worse, with mean values: sperm concentration (7.63±4.91) and PR motility (22.21±7.63). Conclusions Follow-up hormonal evaluation during hypothalamic estrogen receptor antagonist treatment should be mandatory, as elevated gonadotropin levels may have a negative impact on semen parameters, gynecomastia, and overall testicular function. Conflicts of Interest No conflict of interest to delcare.
urology & nephrology